Skip to main content
General Medicine

Intraductal Papillary Mucinous Neoplasm

Dongsheng Jiang, MS, MD and Joanna Jiang, MD Reviewed 04/2024
 


BASICS

Intraductal papillary mucinous neoplasms (IPMNs) are the most common pancreatic cystic neoplasms (PCNs). They account for 10–13% of all pancreatic cysts, 25–50% of all cystic pancreatic neoplas...

DIAGNOSIS

HISTORY

  • Clinical presentation is often nonspecific and IPMNs are often an incidental finding on imaging for other reasons (1)

  • MD-IPMNs may present with abdominal pain or with acute pancreati...

TREATMENT

GENERAL MEASURES

Individualized management, follow-up, and surveillance by a multidisciplinary physician team at a hospital with high-volume of pancreatic operations is recommended. 

SURGERY/OTHER PROCEDURES

ONGOING CARE

FOLLOW-UP RECOMMENDATIONS

The vast majority of IPMNs are currently kept under surveillance (2). The frequency of follow-up investigations and the surveillance after resection are controve...

REFERENCES

1
Paramythiotis D, Karlafti E, Fotiadou G, et al. Pancreatic Intraductal Papillary Mucinous Neoplasms: A Narrative Review. Acta Med Litu. 2023;30(1):53-65. doi: 10.15388/Amed.2023.30.1.6. PM...

CLINICAL PEARLS

  • IPMNs is a common clinical finding.

  • They are premalignant lesions.

  • Its natural history is still unclear.

  • There are over 10 guidelines on IPMNs and there is no clear consensus on its overa...

Subscribe to Access Full Content

Sign Up for a 10-Day Free Trial

Sign up for a 10-day FREE Trial now and receive full access to all content.

START 10-DAY FREE TRIAL
Subscribe Now
GET CME/CE
 
©2025 Wolters Kluwer Health, Inc. and/or its subsidiaries. All rights reserved.
Enter an Access Code
Enter the code from your copy of The 5-Minute Clinical Consult or another access code to create an account.
Redeem
×